Novo Nordisk's Rybelsus has become the first oral GLP-1 agonist to pick up a regulatory approval for cardiovascular risk reduction, after getting a green light from the EMA's human medicine committee.
6d
Firefly Metals Announces Mineral Resource Increased By 51% At Green Bay Copper Gold Project, Canada
Firefly Metals Announces Mineral Resource Increased By 51% At Green Bay Copper Gold Project, Canada. Exceptional result includes a spectacular high-grade Mineral Resource of 8.8Mt @ 3.9% CuEq (346kt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback